The secret life of steroids in asthma

European Respiratory Journal

Volumn 32, Issue 5, 2008, Pages 1135-1137

  Sterk, P J ^a   Yick, C Y ^a   Slats, A M ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; DEXAMETHASONE; HEAT SHOCK PROTEIN 27; IMMUNOGLOBULIN E ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

AIRWAY OBSTRUCTION; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; CORTICOSTEROID THERAPY; DRUG MECHANISM; DRUG TARGETING; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; LUNG FUNCTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESPIRATORY FUNCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; STEROID THERAPY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; PHENOTYPE; RESPIRATION DISORDERS; STEROIDS;

EID: 58849145583     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00135508     Document Type: Editorial

References (31)

1. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-178.
2. Harris MS. Cortisone in treatment of bronchial asthma. Calif Med 1951; 75: 85-88.
3. Hanania NA. Targeting airway inflammation in asthma: current and future therapies. Chest 2008; 133: 989-998.
4. Voulgari PV. Emerging drugs for rheumatoid arthritis. Expert Opin Emerg Drugs 2008; 13: 175-196.
5. Macklem PT. Emergent phenomena and the secrets of life. J Appl Physiol 2008; 104: 1844-1846.
6. van Schoor J, Joos GF, Pauwels RA. Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. Eur Respir J 2000; 16: 514-533.
7. Global Initiative for Asthma. 2004 Update: Workshop Report, Global Strategy for Asthma Management and Prevention. www.ginasthma.org/Guidelineitem. asp?l1=2&l2=1&intId=87.
8. Palmans E, Kips JC, Pauwels RA. Prolonged allergen exposure induces structural airway changes in sensitized rats. Am J Respir Crit Care Med 2000; 161: 627-635.
9. Southam DS, Ellis R, Wattie J, Inman MD. Components of airway hyperresponsiveness and their associations with inflammation and remodeling in mice. J Allergy Clin Immunol 2007; 119: 848-854.
10. Berry MA, Hargadon B, Shelley M, et al. Evidence of role of tumor necrosis factor-α in refractory asthma. N Engl J Med 2006; 354: 697-708.
11. Van Rensen ELJ, Evertse CE, van Schadewijk AAM, et al. Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment. Allergy 2008; (In press).
12. Mauad T, Bel EH, Sterk PJ. Asthma therapy and airway remodeling. J Allergy Clin Immunol 2007; 120: 997-1009.
13. Siddiqui S, Mistry V, Doe C, et al. Airway hyperresponsiveness is dissociated from airway wall structural remodelling. J Allergy Clin Immunol 2008; 122: 335-341.
14. Brightling C, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346: 1699-1705.
15. Slats AM, Janssen K, van Schadewijk A, et al. Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176: 121-128.
16. Möller GM, Overbeek SE, van Helden-Meeuwsen CG, Hoogsteden HC, Bogaard JM. Eosinophils in the bronchial mucosa in relation to methacholine dose-response curves in atopic asthma. J Appl Physiol 1999; 86: 1352-1356.
17. Lakser OJ, Dowell ML, Hoyte FL, et al. Steroids augment relengthening of contracted airway smooth muscle: potential additional mechanism of benefit in asthma. Eur Respir J 2008; 32: 1224-1230.
18. Skloot G, Permutt S, Togias A. Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest 1995; 96: 2393-2403.
19. Fredberg JJ. Bronchospasm and its biophysical basis in airway smooth muscle. Respir Res 2004; 5: 2.
20. An SS, Bai TR, Bates JL, et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Repir J 2007; 29: 834-860.
21. Lakser OJ, Lindeman RP, Fredberg JJ. Inhibition of the p38 MAP kinase pathway destabalizes smooth muscle length during physiological loading. Am J Physiol Lung Cell Mol Physiol 2002; 282: L1117-L1121.
22. Tliba O, Amrani Y, Panettieri RA. Is airway smooth muscle the "missing link" modulating airway inflammation in asthma? Chest 2008; 133: 236-242.
23. Halayko AJ, Tran T, Ji SY, Jamasaki A, Gosens R. Airway smooth muscle phenotype and function: interactions with current asthma therapies. Curr Drug Targets 2006; 7: 525-540.
24. Barnes PJ. Corticosteroid effects on cell signalling. Eur Respir J 2006; 27: 413-426.
25. Hakonarson H, Halapi E, Whelan R, Gulcher J, Stefansson K, Grunstein MM. Association between IL-1β/TNF-α induced glucocorticoid-sensitive changes in multiple gene expression and altered responsiveness in airway smooth muscle. Am J Respir Cell Mol Biol 2002; 25: 761-771.
26. Kang BN, Jude JA, Panettieri RA, Walseth TF, Kannan MS. Glucocorticoid regulation of CD38 expression in human airway smooth muscle cells: role of dual specificity phosphatase 1. Am J Physiol Cell Mol Physiol 2008; 295: L186-L193.
27. Zuyderduyn S, Sukkar MB, Dhaliwal S, Burgess JK. Treating asthma means treating airway smooth muscle cells. Eur Respir J 2008; 32: 265-274.
28. Slats AM, Janssen K, van Schadewijk A, et al. Expression of smooth muscle and extracellular matrix proteins in relation to airway function in asthma. J Allergy Clin Immunol 2008; 121: 1196-1202.
29. Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992; 90: 32-42.
30. Bel EH, Timmers MC, Hermans J, Dijkman JH, Sterk PJ. The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in non-atopic asthmatic subjects. Am Rev Respir Dis 1990; 141: 21-28.
31. Adcock IM, Barnes PJ. Molecular mechanisms of corticosteroid resistance. Chest 2008; 134: 394-401.